These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 10706409

  • 21. Sex difference in the oxidative metabolism of delta 9-tetrahydrocannabinol in the rat.
    Narimatsu S, Watanabe K, Yamamoto I, Yoshimura H.
    Biochem Pharmacol; 1991 Apr 15; 41(8):1187-94. PubMed ID: 1848985
    [Abstract] [Full Text] [Related]

  • 22. Stereospecific and regioselective hydrolysis of cannabinoid esters by ES46.5K, an esterase from mouse hepatic microsomes, and its differences from carboxylesterases of rabbit and porcine liver.
    Watanabe K, Matsunaga T, Kimura T, Funahashi T, Yamaori S, Shoyama Y, Yamamoto I.
    Biol Pharm Bull; 2005 Sep 15; 28(9):1743-7. PubMed ID: 16141551
    [Abstract] [Full Text] [Related]

  • 23. Cytochrome P-450 isozymes in metabolic activation of delta 9-tetrahydrocannabinol by rat liver microsomes.
    Narimatsu S, Watanabe K, Matsunaga T, Yamamoto I, Imaoka S, Funae Y, Yoshimura H.
    Drug Metab Dispos; 1990 Sep 15; 18(6):943-8. PubMed ID: 1981541
    [Abstract] [Full Text] [Related]

  • 24. Effect of repeated administration of 11-hydroxy-delta 8-tetrahydrocannabinol, an active metabolite of delta 8-tetrahydrocannabinol, on the hepatic microsomal drug-metabolizing enzyme system of mice.
    Watanabe K, Arai M, Narimatsu S, Yamamoto I, Yoshimura H.
    Biochem Pharmacol; 1986 Jun 01; 35(11):1861-5. PubMed ID: 3013200
    [Abstract] [Full Text] [Related]

  • 25. Competitive inhibition of delta8-tetrahydrocannabinol and its active metabolites for cannabinoid receptor binding.
    Yamamoto I, Kimura T, Kamei A, Yoshida H, Watanabe K, Ho IK, Yoshimura H.
    Biol Pharm Bull; 1998 Apr 01; 21(4):408-10. PubMed ID: 9586583
    [Abstract] [Full Text] [Related]

  • 26. Metabolism of delta 9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeys.
    Matsunaga T, Iwawaki Y, Watanabe K, Yamamoto I, Kageyama T, Yoshimura H.
    Life Sci; 1995 Apr 01; 56(23-24):2089-95. PubMed ID: 7776836
    [Abstract] [Full Text] [Related]

  • 27. Long-retained metabolites of delta9- and delta8-tetrahydrocannabinols identified as novel fatty acid conjugates.
    Leighty EG, Fentiman AF, Foltz RL.
    Res Commun Chem Pathol Pharmacol; 1976 May 01; 14(1):13-28. PubMed ID: 935647
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the effects of 11-palmitoyloxy-delta 9-tetrahydrocannabinol with delta 9-tetrahydrocannabinol and 11-hydroxy-delta 9-tetrahydrocannabinol on the hepatic microsomal drug-metabolizing enzyme system.
    Leighty EG.
    Res Commun Chem Pathol Pharmacol; 1979 Sep 01; 25(3):525-35. PubMed ID: 116333
    [Abstract] [Full Text] [Related]

  • 29. Involvement of CYP2C in the metabolism of cannabinoids by human hepatic microsomes from an old woman.
    Watanabe K, Matsunaga T, Yamamoto I, Funae Y, Yoshimura H.
    Biol Pharm Bull; 1995 Aug 01; 18(8):1138-41. PubMed ID: 8535411
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
    Bullock P, Pearce R, Draper A, Podval J, Bracken W, Veltman J, Thomas P, Parkinson A.
    Drug Metab Dispos; 1995 Jul 01; 23(7):736-48. PubMed ID: 7587963
    [Abstract] [Full Text] [Related]

  • 34. Marihuana-like activity of new synthetic tetrahydrocannabinols.
    Martin BR, Dewey WL, Harris LS, Beckner J.
    Pharmacol Biochem Behav; 1975 Jul 01; 3(5):849-53. PubMed ID: 1208625
    [Abstract] [Full Text] [Related]

  • 35. Oxidation of R(+)- and S(-)-carvedilol by rat liver microsomes. Evidence for stereoselective oxidation and characterization of the cytochrome P450 isozymes involved.
    Fujimaki M.
    Drug Metab Dispos; 1994 Jul 01; 22(5):700-8. PubMed ID: 7835220
    [Abstract] [Full Text] [Related]

  • 36. Major cytochrome P450 enzymes responsible for microsomal aldehyde oxygenation of 11-oxo-Delta8-tetrahydrocannabinol and 9-anthraldehyde in human liver.
    Watanabe K, Matsunaga T, Kimura T, Funahashi T, Funae Y, Ohshima T, Yamamoto I.
    Drug Metab Pharmacokinet; 2002 Jul 01; 17(6):516-21. PubMed ID: 15618706
    [Abstract] [Full Text] [Related]

  • 37. Spectral interaction of 11-hydroxy-delta-8-tetrahydrocannabinol with rabbit and rat liver microsomal cytochrome P-450.
    Watanabe K, Oguri K, Yoshimura H.
    Chem Pharm Bull (Tokyo); 1980 Jun 01; 28(6):1939-42. PubMed ID: 6250733
    [No Abstract] [Full Text] [Related]

  • 38. Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450.
    Miller KK, Cai J, Ripp SL, Pierce WM, Rushmore TH, Prough RA.
    Drug Metab Dispos; 2004 Mar 01; 32(3):305-13. PubMed ID: 14977864
    [Abstract] [Full Text] [Related]

  • 39. Recent advances in the metabolism of cannabinoids.
    Yamamoto I, Watanabe K, Narimatsu S, Yoshimura H.
    Int J Biochem Cell Biol; 1995 Aug 01; 27(8):741-6. PubMed ID: 7584607
    [Abstract] [Full Text] [Related]

  • 40. Effects of unsaturated side-chain analogs of tetrahydrocannabinol on cytochromes P450.
    Bornheim LM.
    Biochem Pharmacol; 2000 Oct 01; 60(7):955-61. PubMed ID: 10974204
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.